SkepSkep
All episodes
The Morning Brief — Sun–Organon: The scope, risks, and future of India's biggest pharma deal
Scout ratingSCOUT· 29%16m·2026-04-30·News Politics

Sun–Organon: The scope, risks, and future of India's biggest pharma deal

The Morning Brief · 945

India's largest drugmaker, Sun Pharma, has announced the acquisition of US-based Organon in a landmark $11.75 billion all-cash deal, the biggest overseas purchase by an Indian company since Tata-Corus in 2007. The move effectively doubles Sun Pharma's size, vaulting it into the top 25 global pharmaceutical companies…

Listen now
Buzzmeter · cross-platform
Scout rating
29%
SCOUT

Scout bees are checking it out — divided opinions, the swarm hasn't committed.

Hive Vote · Skep listeners
New on SkepAwaiting the hive's first votes

Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.

Rate this episode

Add your vote to the Hive — listeners rate every episode after they finish.

Rate this episode
Recent reviews
  • No reviews yet — be the first.

One great episode in your inbox, daily — free.

One email a day, unsubscribe anytime. No spam, ever.